Should we exclude acute stroke patients with previous intracerebral hemorrhage from receiving intravenous thrombolysis?

about

Should we exclude acute stroke patients with previous intracerebral hemorrhage from receiving intravenous thrombolysis?

Item

http://www.wikidata.org/entity/Q48671267

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Should we exclude acute stroke ...... ving intravenous thrombolysis?

@en

Should we exclude acute stroke ...... ving intravenous thrombolysis?

@nl

type

Item

label

Should we exclude acute stroke ...... ving intravenous thrombolysis?

@en

Should we exclude acute stroke ...... ving intravenous thrombolysis?

@nl

prefLabel

Should we exclude acute stroke ...... ving intravenous thrombolysis?

@en

Should we exclude acute stroke ...... ving intravenous thrombolysis?

@nl

P1476

Should we exclude acute stroke ...... ving intravenous thrombolysis?

@en

P2093

Beom Joon Kim

http://www.w3.org/2001/XMLSchema#string

Byung-Chul Lee

http://www.w3.org/2001/XMLSchema#string

Dae-Hyun Kim

http://www.w3.org/2001/XMLSchema#string

Dong-Eog Kim

http://www.w3.org/2001/XMLSchema#string

Dong-Ick Shin

http://www.w3.org/2001/XMLSchema#string

Hee-Joon Bae

http://www.w3.org/2001/XMLSchema#string

Hyun-Wook Nah

http://www.w3.org/2001/XMLSchema#string

Jae Guk Kim

http://www.w3.org/2001/XMLSchema#string

Jae Kwan Cha

http://www.w3.org/2001/XMLSchema#string

Jay Chol Choi

http://www.w3.org/2001/XMLSchema#string

P2860

Heart Disease and Stroke Statistics--2015 Update: A Report From the American Heart Association

Case characteristics, hyperacute treatment, and outcome information from the clinical research center for stroke-fifth division registry in South Korea

Markers of increased risk of intracerebral hemorrhage after intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke in clinical practice: the Multicenter rt-PA Stroke Survey

Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges

Tissue plasminogen activator for acute ischemic stroke

Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association

MRI-based Algorithm for Acute Ischemic Stroke Subtype Classification.

Eligibility for Intravenous Recombinant Tissue-Type Plasminogen Activator Within a Population: The Effect of the European Cooperative Acute Stroke Study (ECASS) III Trial.

Hemorrhagic complications after off-label thrombolysis for ischemic stroke.

Hemorrhagic transformation: a review of the rate of hemorrhage in the major clinical trials of acute ischemic stroke.

P304

783-790

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1747493016654289

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Keun-Sik Hong

Moon-Ku Han

P577

2016-06-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27312681

http://www.w3.org/2001/XMLSchema#string

P921

thrombolysis